Institute of Information Management (IIM) Australia Successfully Concludes 2025 Annual Conference, Induction & Investiture in Brisbane
With the theme "Navigating Data Integrity and Compliance in the Australian Digital Landscape," the event brought together distinguished professionals, industry leaders, inductees, and guests from both the public and private sectors. Participants joined both in person and virtually to explore emerging challenges and opportunities in data governance.
The conference began with an opening address by IIM International President, Amb. (Dr.) Oyedokun Ayodeji Oyewole, CCDOA, FIIM. In his remarks, Dr. Oyewole emphasized the growing significance of data integrity and compliance in an era of rapid technological change and increasing regulatory demands.
A key highlight of the day was the keynote presentation delivered by Ms. Kate Carruthers (FGIA, MAICD), Director of Info Sphere Education Pty Ltd, Sydney. Her address, titled "The New Rules of Data: Compliance, Conflict, and Competitive Advantage," offered attendees a compelling exploration of the evolving regulatory environment in Australia and beyond. Ms. Carruthers examined global data management trends, the human dimension of data, and practical strategies for organizations navigating new compliance frameworks.
She shed light on critical developments such as the Privacy and Other Legislation Amendment Act (December 2024), the Cyber Security Act 2024, and updated standards impacting critical infrastructure and financial institutions. Emphasizing integrated federal legislation, mandatory ransomware reporting, and enhanced protections for vulnerable groups—including children and victims of doxing—Ms. Carruthers underscored the imperative for organizations to embed data integrity, trust, and transparency into their core operations.
The event also featured the formal induction of new members into the IIM Australia community across various categories, including Honorary Fellow, Professional Fellow, and Associate Member. The investiture ceremony recognized these individuals' outstanding contributions to the field of information management and their dedication to upholding professional excellence.
The 2025 Annual Conference reaffirmed IIM Australia's unwavering commitment to promoting thought leadership, regulatory awareness, and excellence in data governance amid the ongoing digital transformation.
For further information about IIM Australia and upcoming events, please contact:
Institute of Information Management (IIM) AustraliaHillcrest, Queensland AustraliaEmail: info@iim-africa.org
Celestine AchiCell: +234-08099997175Email: Celestine.achi@gmail.com
Photo - https://mma.prnewswire.com/media/2668645/IIM.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/institute-of-information-management-iim-australia-successfully-concludes-2025-annual-conference-induction--investiture-in-brisbane-302432964.html
SOURCE Institute of Information Management
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
Vitamin B12 Market Set to Surpass USD 444.47 Million by 2030, Driven by Rising Veganism, Preventive Healthcare Focus, and Growth in Nutraceuticals: MarkNtel Advisors
NEW DELHI, Aug. 14, 2025 /PRNewswire/ -- The Global Vitamin B12 Market is on track to grow from USD 288 million in 2024 to USD 444.47 million by 2030, representing a compound annual growth rate (CAGR) of 7.50%, according to the latest industry research. The market's expansion is being fueled by heightened consumer awareness of Vitamin B12's critical role in human health, alongside a surge in plant-based dietary patterns, and rapid advances in the nutraceutical and fortified food industries. Vitamin B12, scientifically known as cobalamin, is a water-soluble vitamin essential for red blood cell formation, neurological function, and DNA synthesis. Naturally occurring in animal-derived foods such as meat, fish, eggs, poultry, and dairy, it is notably absent from plant-based diets — creating a significant risk of deficiency among vegans, vegetarians, and individuals with certain medical conditions that affect nutrient absorption. Deficiency symptoms can include fatigue, weakness, anemia, cognitive decline, and nerve damage. For An In-Depth Breakdown of Market Trends, Forecasts, and Industry Segmentation, Download Free Sample of the Report Here: Leading Companies in the Vitamin B12 Market: The competitive landscape of the global Vitamin B12 market features a strong mix of top Vitamin B12 companies, trusted brands, and leading manufacturers driving innovation and supply worldwide. Key industry players dominating the Vitamin B12 segment include Hebei Yufeng Group, Hebei Huarong Pharmaceutical, BASF Nutrition, Sanofi, NCPC VICTOR, Chempure, Hebei Yuxing Bio-Engineering Co. Ltd, Ningxia Kingvit Pharmaceutical, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., LUPIN, Mylan N.V., Apotex Inc., Bristol Laboratories Ltd., Mankind Pharma, and Biocon, among others. These companies are recognized for their large-scale production capacities, high-quality formulations, and extensive distribution networks, making them crucial contributors to the growth of the global Vitamin B12 market. Why Vitamin B12 Demand is Rising Globally: Increasing Vitamin B12 Deficiency RatesGlobally, healthcare practitioners are diagnosing Vitamin B12 deficiency in a broader range of demographics than ever before. Causes include dietary restrictions, gastrointestinal disorders, age-related absorption issues, and genetic factors. The rise in deficiencies is driving demand for both preventive and therapeutic supplementation across medical, retail, and online channels. Shift Toward Plant-Based NutritionThe rapid growth in vegan and vegetarian populations, driven by environmental, ethical, and health considerations, is significantly reshaping food and supplement markets. Since plant-based diets naturally lack Vitamin B12, fortified foods such as plant-based milks, breakfast cereals, and nutritional yeast have become important dietary staples. Supplementation is now a critical recommendation for those avoiding animal products. Expansion of the Nutraceutical and Functional Food IndustryThe global nutraceutical market is integrating Vitamin B12 into a wide range of formulations, from energy-boosting blends and cognitive health products to immune support and sports recovery supplements. Increasing disposable incomes and the shift toward proactive wellness are fueling retail growth across supermarkets, pharmacies, and e-commerce platforms. Market Segmentation Analysis By Cyanocobalamin Type: Injection: Preferred in clinical environments for treating severe deficiencies, neurological disorders, and anemia. Known for rapid absorption and effectiveness in acute cases. Oral: Tablets, capsules, and gummies dominate the consumer market due to convenience, affordability, and wide availability. Spray: A growing category for fast absorption, targeting both the wellness and sports nutrition markets. By Application: Medical Treatment: The largest revenue segment, supported by healthcare providers and prescription-based supplementation. Food Additives: Increasing demand in fortified plant-based beverages, cereals, and packaged health foods. Feed Supplements: Critical in the livestock and poultry sectors to improve animal health and productivity. Others: Includes pharmaceutical integration and cosmetic formulations targeting skin health. Access Complete Data Tables, Forecasts, and Competitor Profiles Here: Regional Outlook: Asia-Pacific Leading the Growth: Asia-Pacific is projected to dominate the market due to: High prevalence of malnutrition & B12 deficiency in younger populations. Government-led nutrition awareness campaigns in India, China, and Southeast Asia. Rising disposable incomes driving health supplement purchases. North America and Europe will continue to hold substantial market shares, driven by advanced healthcare infrastructure, preventive medicine adoption, and high supplement penetration rates. Key Market Trends: B12-Fortified Vegan Foods: Rapid innovation in fortified plant-based products to meet the needs of vegan and vegetarian consumers. Digital Health Integration: AI-driven nutrition platforms and telehealth services are increasingly recommending tailored B12 supplementation plans. E-Commerce Dominance: Direct-to-consumer supplement sales are surging, with subscription models improving retention rates. Multi-Nutrient Formulations: Combining Vitamin B12 with other vitamins and minerals for holistic health benefits. Challenges and Industry Responses: While Vitamin B12 is generally considered safe, excessive intake can cause mild side effects, including skin irritation, headaches, and dizziness in sensitive individuals. Certain medical conditions, such as Leber's hereditary optic neuropathy, require caution. Industry leaders are responding by implementing clear dosage labeling, robust consumer education campaigns, and third-party testing for quality assurance. Request Your Custom Vitamin B12 Market Report – Regional or Country Specific – Get tailored insights for your exact target market. Related Questions You May Find Helpful: Q1. What is the current size of the global Vitamin B12 market? A. The market is valued at approximately USD 288 million in 2024 and is projected to reach USD 444.47 million by 2030, growing at a CAGR of around 7.50%. Q2. Who are the top Vitamin B12 manufacturers globally? A. Major players include Hebei Yufeng Group, BASF Nutrition, Sanofi, Merck & Co., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., and Mankind Pharma among others. Q3. Which industries use Vitamin B12? A. Key sectors include pharmaceuticals, nutraceuticals, food & beverage, feed supplements, and cosmetics. Q4. Why is demand for Vitamin B12 increasing? A. Rising veganism, increasing vitamin deficiencies, and higher health awareness are driving global demand. Q5. What are the key benefits of Vitamin B12 supplements? A. Supports blood health, DNA synthesis, nerve function, and helps prevent megaloblastic anemia. Q6. Which region leads the Vitamin B12 market? A. Asia-Pacific dominates due to high deficiency rates, rising incomes, and growing vegan/vegetarian populations. Q7. Where can I get a detailed report? A. MarkNtel Advisors offers in-depth Vitamin B12 market analysis with forecasts, segmentation, and competitive intelligence to help businesses make data-driven decisions. Q8. How can I invest in this market? A. Investors can explore partnerships with leading manufacturers, nutraceutical startups, or distribution networks to capitalize on the growing demand. Discover More Market Insights Like This One! – Global Pet Food Packaging Market Research Report: Forecast (2025-2030) - The Global Pet Food Packaging Market size was valued at around USD 11.34 billion in 2024 and is projected to reach USD 15.48 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 5.32% during the forecast period, i.e., 2025-30. Global Edible Insects Market Research Report: Forecast (2025-2030) - The Global Edible Insects Market size was valued at around USD 1.36 billion in 2024 and is projected to reach USD 6.23 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 28.87% during the forecast period, i.e., 2025-30. Global Ethnic Food Market Research Report: Forecast (2025-2030) - The Global Ethnic Food Market size was valued at around USD 78.2 billion in 2024 and is projected to reach USD 120.69 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 7.50% during the forecast period, i.e., 2025-30. Global Craft Beer Market Research Report: Forecast (2025-2030) - The Global Craft Beer Market size was valued at around USD106.4 billion in 2024 and is expected to reach USD179.43 billion by 2030. Global Cargo Drones Market Research Report: Forecast (2025-2030) -The Global Cargo Drones Market size was valued at USD 1.78 Billion in 2024 and is projected to reach USD 9.35 Billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 36% during the forecast period, i.e., 2025-30. About Us – MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others. We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others. Contact Us:MarkNtel AdvisorsOffice No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, IndiaContact No: +91 8719999009Email: sales@ our Website: Source: Logo: View original content: SOURCE MarkNtel Advisors Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Implantica publishes Interim Report January - June 2025 (Q2)
VADUZ, Liechtenstein, Aug. 14, 2025 /PRNewswire/ -- Transforming Clinical Excellence of RefluxStop® into Strategic Market Momentum Significant events in the second quarter of 2025 FDA PMA Submission Completed - Submitted third and final module of the U.S. FDA pre-market approval (PMA) application for RefluxStop®, including responses to questions on the second module; Feedback on module 3 expected in the near-term Produced and completed initial testing on new multi-cavity production tool for RefluxStop® to support launch of manufacturing in U.S. and manage ramp-up of U.S. production (pending FDA approval) Additional preparations for U.S. market launch (pending FDA approval) included U.S. payer and reimbursement activities, finalizing new production facility of RefluxStop® in U.S. and launching our RCT (randomized clinical trial), as a heavyweight cornerstone in building global leadership in acid reflux care Positive NICE Guidance in the UK - UK's National Institute for Health and Care Excellence (NICE) issued positive guidance for the use of RefluxStop® in NHS hospitals for patients with ineffective esophageal motility (IOM/IEM), potentially transforming treatment access for millions and influencing global policy Significant events after the end of the period Landmark 5-Year Clinical Study Results - Two peer-reviewed articles were published in Surgical Endoscopy on our pivotal study results; one publication confirmed outstanding long-term safety and effectiveness outcomes, and the second publication highlighted RefluxStop®'s excellent outcomes in food passageway-related sequelae, which is common in standard of care Randomized Clinical Trial (RCT) Launch - First RCT comparing RefluxStop® with Nissen fundoplication; patient recruitment underway accumulating patients across participating hospitals. While this trial preparation led to a 20% year-on-year revenue decline for Q2, the impact is expected to ease once study recruitment stabilizes Spanish Market Expansion - Three new hospitals added, totaling 19 centers offering RefluxStop® in Spain, with a healthcare sytem receptive for new and better patient care, which is a fantastic launch since 2023 First UK National Users Meeting - Convened 21 top anti-reflux experts to discuss real-world results, operating technique and the opportunities arising from NICE's positive recommendation Financial summary second quarter 2025 Net sales decreased 22% to TEUR 433 (554) due to the launch of the randomized clinical trial with surgeons accumulating patients for the trial. Adjusted gross margin amounted to 90% (91%). Operating loss (EBIT) decreased to TEUR 4,525 (5,869). Loss after tax decreased to TEUR 5,448 (6,431). Basic and diluted loss per Class A share amounted to EUR 0.08 (0.09). Cash and short-term investments as at the end of the period of MEUR 56.3. First six months Net sales increased 2% to TEUR 1,178 (1,150). Adjusted gross margin amounted to 94% (91%). Operating loss (EBIT) decreased to TEUR 8,698 (12,956). Loss after tax decreased to TEUR 8,212 (9,903). Basic and diluted loss per Class A share amounted to EUR 0.12 (0.14). Telephone conference Implantica will hold a teleconference on 14 August 2025 at 15:00 (CEST) with Peter Forsell (CEO), Andreas Öhrnberg (CFO), and Nicole Pehrsson (Chief Corporate Affairs Officer). Please see the dial-in details below to join the conference: Webcast If you wish to participate via webcast, please use the following link: Dial-in Dial-in numbers to the teleconference will be received by registering on the link below. After the registration, you will be provided phone numbers and a conference ID to access the conference. For further information, please contact:Nicole Pehrsson, Chief Corporate Affairs OfficerTelephone (CH): +41 (0)79 335 09 Implantica is listed on Nasdaq First North Premier Growth Market in Stockholm. The company's Certified Adviser is FNCA Sweden AB, info@ This information is information that Implantica AG is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-08-14 08:00 CEST. About Implantica: Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica's lead product, RefluxStop®, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energising platform designed to power remote controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit for further information. This information was brought to you by Cision The following files are available for download: Implantica Q2 2025_ENG Implantica publishes Interim Report Jan - Jun 2025 Q2 View original content:
Yahoo
5 hours ago
- Yahoo
Taiwan's "Star Hotel" and "Taiwan Host B&B" Brands Make Their Debut at 2025 NATAS Holidays Travel Fair in Singapore
TAIPEI, Aug. 14, 2025 /PRNewswire/ -- Taiwan's two official accommodation brands—Taiwan Host B&B and Star Hotel, are making their first appearance at the 2025 NATAS Holidays Travel Fair, holding from August 15–17 at Singapore EXPO Hall 5. Showcasing the warmth of Taiwanese hospitality, the Taiwan Pavilion will offer a range of engaging activities including Taiwan Host B&B ambassador sharing sessions, travel trivia challenges, and social media check-in prize draws. Visitors will also have the exciting opportunity to win a free round-trip flight between Singapore and Taiwan. This news comes from Staynews. Taiwan Host B&B is an official certification program promoting homestays that uphold six core values: friendliness, warmth, cleanliness, hygiene, safety, and quality service. These certified B&Bs offer travelers a high level of service and a comfortable accommodation experience. To date, there are over 1,900 Taiwan Host B&Bs across Taiwan. Among them, 100 "Golden-Award Taiwan Host B&Bs" have been carefully selected and categorized into five themes—Nature & Ecology, Cultural Discovery, Architectural Charm, Family & Pet Travel, and Culinary Delights—designed to meet the diverse travel interests of international visitors. Star Hotels represent another official accommodation brand from Taiwan, selected through a rigorous evaluation process by mystery inspectors who assess over 500 items across both hardware and service. Hotels are ranked from 1 to 3 stars (basic, budget, and comfort) to 4 and 5 stars (deluxe and premium), with a special "5-Star Excellence" level for top-tier properties. There are currently nearly 200 government-certified Star Hotels in Taiwan. These hotels serve as a trusted guide for travelers, providing assurance in both facilities and service quality. A special highlight at the pavilion will be sharing sessions by Golden-Award Taiwan Host B&B ambassadors, who will introduce the unique charms of homestays across Taiwan, covering themes such as nature experiences, cultural immersion, and family/pet-friendly stays. A B&B owner from Kinmen will also host a demonstration of the Mid-Autumn Festival dice game "Bo Bing", along with free tastings of Kinmen's signature souvenirs like peanut brittle and mini pastries, offering Singaporean visitors a nostalgic taste of Nanyang flavor and showcasing the deep connection between Taiwan's local culture and overseas heritage. Visitors who join guided tours of the Taiwan Host B&B and Star Hotel booths and complete a short questionnaire will receive a free bilingual handbook featuring the Golden-Award Taiwan Host B&Bs, along with the chance to take home limited-edition gifts. This appearance at the NATAS Holidays Travel Fair is a milestone in the international outreach of Taiwan's accommodation brands, offering travelers in Singapore a first-hand look at Taiwan's heartfelt hospitality and the character of its accommodation experiences. For more information about Taiwan Host B&Bs and Star Hotels, please visit: (Press release from Staynews : View original content to download multimedia: SOURCE StayNews
